EQS-Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing

Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing 26-Apr-2022 / 07:00 CET/CEST Release of an ad hoc

Related Keywords

Geneva ,Genè ,Switzerland ,Secheron ,Switzerland General ,Swiss ,Zinuara Pharma ,Anthony Kim ,Michael Miller ,Jack Weinstein ,Advita Lifescience Gmb ,Relief Therapeutics Holding Sa Key ,Linkedin ,Rx Communications Group ,Cubist Pharmaceuticals ,Intercept Pharmaceuticals ,Brown University ,News Service ,Division Of Health Sciences ,Pharma Research ,Swiss Exchange ,Exchange Commission ,Harvard Business School ,Master Of Business Administration ,Us Marketing At Intercept Pharmaceuticals Inc ,Us Marketing Department ,Relief Therapeutics Holding ,Neurorx Inc ,Therapeutics Appoints Drew Cronin Fine ,Executive Director ,Rare Diseases ,Digital Innovation ,New Product Launches ,Drew Cronin Fine ,Senior Vice President ,Drug User Fee Act ,Urea Cycle Disorders ,Acer Therapeutics ,Relief Therapeutics ,Associate Director ,Chief Operating Officer ,Business Administration ,Health Sciences ,Vasoactive Intestinal Peptide ,License Agreement ,Maple Syrup Urine ,Advita Lifescience Gmbh ,Financial Officer ,Adhoc ,Relief ,Herapeutics ,Molding ,Ppoints ,Crew ,Cronin ,Line ,Executive ,Director ,Head ,Marketing ,